At AIMS Institute we prescribe low dose oral naltrexone for ‘long COVID’

A recent paper in the Frontiers in Medicine states that

An underutilized intervention for long  COVID is low dose naltrexone, which has an established safety profile for a variety of conditions. ‘Naltrexone is a non-selective opioid antagonist currently approved by the US Food and Drug Administration (FDA) for the treatment of alcohol and opioid dependence and is prescribed at 50–150 mg daily. At doses below 5 mg, it is considered low-dose naltrexone (LDN), exhibits anti-inflammatory and analgesic properties, and has been used off-label to reduce severity of symptoms in conditions such as fibromyalgia, multiple sclerosis, complex regional pain syndrome, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and Crohn’s disease. LDN is widely available with a prescription, also at a low cost, and is associated with minimal side effects. LDN has been associated with improvement of several clinical symptoms related to long COVID such as fatigue, poor sleep quality and pattern, brain fog, post-exertional malaise, headache, and demonstrated reduction of symptoms and improvement of functionality. In patients living with long COVID presenting with neuropsychiatric symptoms, fatigue, or exertional intolerance, consider utilization or adjunct therapy with LDN.

https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1430444/full

Leanna Standish, ND, PhD, LAc, FABNO 
Co-Director, AIMS Institute PLLC
CEO, Sacred Medicines PBC
 
At AIMS Institute we prescribe low dose oral naltrexone for ‘long COVID’

Latest Blog Posts

AIMS INSTITUTE’S COGNITIVE DECLINE PROTOCOL

AIMS INSTITUTE’S COGNITIVE DECLINE PROTOCOL

LJ STANDISH AND DAVID JAMES Dr. Standish and her team can help improve brain function, improve memory and slow cognitive decline in Alzheimer’s disease.  Please make an appointment to start.  Call 206-420-1321.  Scientific Rationale A protocol incorporating low-dose lithium orotate, Lion’s Mane mushroom extract, NADH, transcranial magnetic stimulation (TMS), and blood sugar regulation counseling is scientifically rational for treating cognitive decline based on mechanistic, preclinical, and emerging human studies. Low-Dose Lithium Orotate (5 mg/day) Recent brain tissue studies link low brain lithium to the onset and progression of Alzheimer’s disease, with deficiency accelerating synaptic loss and cognitive decline. Low-dose lithium orotate has ...

Read More
One Doctor’s Campaign to Let the Dying Take Psychedelics

One Doctor’s Campaign to Let the Dying Take Psychedelics

Psilocybin mushrooms on a dehydrator tray. Photographer: Jason Connolly/AFP/Getty Images By Charles Gorrivan September 3, 2025 at 3:00 AM PDT Corrected September 3, 2025 at 9:04 AM PDT Hi, it’s Charles in New York. When Brave New World author Aldous Huxley was on his deathbed in 1963, his wife injected him with two doses of LSD, the powerful psychedelic, as he slipped away. Was Huxley on to something? More on that in a moment, but first … Today’s must-reads RFK Jr. set new priorities for the CDC after firing its director. A big Danish pension fund bets that Novo Nordisk ...

Read More
Call Us Text Us
Skip to content